ReviewDrugs & aging2012
Antimuscarinic treatment in overactive bladder: special considerations in elderly patients.
Review in Drugs & aging, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Risk of delirium associated with antimuscarinics in older adults: A case-time-control study.Pharmacoepidemiology and drug safety · 2022Article
- Management of Overactive Bladder in Older Women.Current urology reports · 2018Review
- The aging bladder insights from animal models.Asian journal of urology · 2018Review
- Older People's Preferences for Side Effects Associated with Antimuscarinic Treatments of Overactive Bladder: A Discrete-Choice Experiment.Drugs & aging · 2017Article
- An overlooked effect of systemic anticholinergics: alteration on accommodation amplitude.International journal of ophthalmology · 2016Article
- Factors affecting medication discontinuation in patients with overactive bladder symptoms.Obstetrics & gynecology science · 2015Article
- Translational Research and Functional Changes in Voiding Function in Older Adults.Clinics in geriatric medicine · 2015Review
- Review of the efficacy and safety of fesoterodine for treating overactive bladder and urgency urinary incontinence in elderly patients.Drugs & aging · 2015Review
- Anticholinergic medication use for female overactive bladder in the ambulatory setting in the United States.International urogynecology journal · 2014Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Overactive bladder is a common condition that increases in prevalence in association with age. Antimuscarinic therapy remains the mainstay of pharmacological treatment for the condition, and there is an increasing body of evidence that supports the use of these drugs. Despite this, and because of concerns about associated adverse effects, older people are less likely to receive active treatment for their condition. This review considers some of the factors that need to be taken into account when using these medications.
Indexed as
Identifiers
22715861What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.